HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interaction of sigma-1 receptor modulators with seizure development in pentylenetetrazole-induced kindled mice.

Abstract
This study aimed to investigate the effects of sigma receptor modulators, opipramol and BD-1063, on epileptogenesis in pentylenetetrazole (PTZ)-kindling model of epilepsy. Mice (n = 6/group) were received PTZ (30 mg/kg), PTZ plus opipramol (5 or 10 mg/kg), PTZ plus opipramol (5 mg/kg) plus BD-1063 (5 mg/kg, a selective sigma-1 receptor antagonist), and PTZ plus BD-1063 on alternate days for 15 days. Opipramol (5 and 10 mg/kg) + PTZ groups became fully kindled and had higher seizure scores compared to the PTZ group. In contrast, the PTZ plus BD-1063 and the PTZ plus opipramol (5 mg/kg) plus BD-1063 group did not show full kindling. These findings indicate that opipramol has a pro-convulsant effect, which is possibly mediated through activation of sigma-1 receptors.
AuthorsMasoumeh Emamghoreishi, Marzieh Shahpari, Mojtaba Keshavarz
JournalEpilepsy research (Epilepsy Res) Vol. 154 Pg. 74-76 (08 2019) ISSN: 1872-6844 [Electronic] Netherlands
PMID31078073 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier B.V. All rights reserved.
Chemical References
  • 1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine
  • Adrenergic Uptake Inhibitors
  • Convulsants
  • Piperazines
  • Receptors, sigma
  • sigma-1 receptor
  • Opipramol
  • Pentylenetetrazole
Topics
  • Adrenergic Uptake Inhibitors (toxicity)
  • Animals
  • Convulsants (toxicity)
  • Kindling, Neurologic (drug effects, physiology)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Opipramol (toxicity)
  • Pentylenetetrazole (toxicity)
  • Piperazines (pharmacology, therapeutic use)
  • Random Allocation
  • Receptors, sigma (agonists, antagonists & inhibitors, physiology)
  • Seizures (chemically induced, physiopathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: